Filters

Neostigmine manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

neostigmine

Injection 2.5 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, ANVISA, INVIMA
Manufacturer #11735
Indian pharmaceutical manufacturer established in the 1980s with over four decades of experience producing Rx tablets, capsules, oral liquids, ointments, and eye drops. Exports to 80+ countries across Asia, Africa, Latin America, and CIS markets. Holds WHO-GMP, EU-GMP, PIC/s, ANVISA, COFEPRIS, and DIGEMID regulatory approvals.

Manufacturer usually replies in 14 days

neostigmine

Injection 2.5 mg/5 ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #35915

Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 13 days

neostigmine + glycopyrronium bromide

Solution for injection 2.5 mg + 0.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Available for
Licensing with supply
Manufacturer #15910
This multinational pharmaceutical company focuses on a wide range of products, including prescription medications, over-the-counter drugs, APIs, and formulations. They have a strong presence in key global regions like North America, Europe, Japan, and Africa. Their expertise spans multiple therapeutic areas, particularly gastroenterology, cardiology, gynecology, diabetology, and oncology. They are known for their state-of-the-art manufacturing facilities that adhere to international standards such as USFDA, EU, MHRA UK, WHO Geneva, and TGA Australia. The company boasts a dedicated R&D team of over 350 scientists working on innovations in areas with unmet medical needs. They have achieved significant milestones by developing "world's first" innovations in lung cancer, tuberculosis, cardiovascular diseases, and gastroenterology. Their product portfolio includes a variety of dosage forms and they hold several patents for their innovative products.

Manufacturer usually replies in 55 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.